[1] A Multivalent Approach to the Design and Discovery of Orally Efficacious 5-HT4 Receptor Agonists
J. Med. Chem., 2009, 52 (17), pp 5330-5343
[2] Long DD, et al. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation. Bioorg Med Chem Lett. 2012 Oct 1;22(19):6048-52. DOI:
10.1016/j.bmcl.2012.08.051[3] Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum AA, Humphrey PP, Marquess DG, et al. Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4849-53. DOI:
10.1016/j.bmcl.2012.05.034 
